In metabolic disorders, the presence of several factors that are linked to abnormally high glucose levels, such as hyperinsulinemia, dyslipidemia, and oxidative stress, lead to a decrease of PON1 activity, especially due to glycation of HDL-PON1 [138]. Here, PON1 is linked to metabolic disease.